Novo Sweetens Its Bid For Metsera, Pledging Up To $10 Billion - Investor's Business Daily

Novo Nordisk said it would pay up to $10 billion to acquire obesity-focused Metsera, topping Pfizer's recently hiked bid.

You will be redirected in 10 seconds.